Open to all DD. BJCT has the tech and the model to make itself into a very significant player if not the leader in needle-free tech. Once the distribution is established world-wide the sales will follow. We just need some good marketing and to get current when the time is right.
Lots of upside.. the spread being wide can deter investors but when they buy the PPS jumps. Most of the shares are under institutional lockdown so the float is tight.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.